Compass Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.9M | Sell |
105,632
-8,651
| -8% | -$4.69M | 3.14% | 19 |
|
|
2025
Q4 | $66.2M | Sell |
114,283
-22,167
| -16% | -$12.5M | 3.68% | 6 |
|
|
2025
Q3 | $66.2M | Sell |
136,450
-15,402
| -10% | -$7.17M | 3.5% | 6 |
|
|
2025
Q2 | $61.6M | Buy |
151,852
+40,068
| +36% | +$16.8M | 3.3% | 11 |
|
|
2025
Q1 | $55.6M | Buy |
111,784
+2,909
| +3% | +$1.58M | 3.66% | 20 |
|
|
2024
Q4 | $56.6M | Buy |
108,875
+6,738
| +7% | +$3.7M | 3.71% | 18 |
|
|
2024
Q3 | $63.2M | Sell |
102,137
-702
| -0.7% | -$416K | 4% | 9 |
|
|
2024
Q2 | $56.9M | Sell |
102,839
-941
| -0.9% | -$539K | 3.81% | 19 |
|
|
2024
Q1 | $60.3M | Buy |
103,780
+971
| +0.9% | +$545K | 3.9% | 14 |
|
|
2023
Q4 | $54.6M | Buy |
102,809
+7,288
| +8% | +$3.53M | 3.86% | 16 |
|
|
2023
Q3 | $48.4M | Sell |
95,521
-3,982
| -4% | -$2.12M | 3.8% | 18 |
|
|
2023
Q2 | $51.9M | Buy |
99,503
+3,725
| +4% | +$2.01M | 3.74% | 19 |
|
|
2023
Q1 | $55.2M | Sell |
95,778
-995
| -1% | -$561K | 4.23% | 4 |
|
|
2022
Q4 | $53.3M | Sell |
96,773
-1,407
| -1% | -$746K | 4.37% | 2 |
|
|
2022
Q3 | $49.8M | Sell |
98,180
-2,074
| -2% | -$1.16M | 4.37% | 4 |
|
|
2022
Q2 | $54.5M | Buy |
100,254
+184
| +0.2% | +$101K | 4.47% | 2 |
|
|
2022
Q1 | $59.1M | Buy |
100,070
+1,107
| +1% | +$636K | 4.21% | 3 |
|
|
2021
Q4 | $66M | Sell |
98,963
-4,219
| -4% | -$2.63M | 4.42% | 2 |
|
|
2021
Q3 | $59M | Sell |
103,182
-5,814
| -5% | -$3.19M | 4.54% | 2 |
|
|
2021
Q2 | $55M | Buy |
108,996
+8,164
| +8% | +$3.85M | 4.21% | 5 |
|
|
2021
Q1 | $46M | Buy |
100,832
+4,197
| +4% | +$2M | 3.9% | 15 |
|
|
2020
Q4 | $45M | Sell |
96,635
-4,296
| -4% | -$2.01M | 3.94% | 11 |
|
|
2020
Q3 | $44.6M | Sell |
100,931
-7,024
| -7% | -$2.9M | 4.32% | 4 |
|
|
2020
Q2 | $39.1M | Sell |
107,955
-7,702
| -7% | -$2.58M | 4.28% | 5 |
|
|
2020
Q1 | $32.8M | Sell |
115,657
-7,744
| -6% | -$2.44M | 4.24% | 3 |
|
|
2019
Q4 | $40.1M | Sell |
123,401
-886
| -0.7% | -$269K | 4.33% | 2 |
|
|
2019
Q3 | $36.2M | Buy |
124,287
+155
| +0.1% | +$44.4K | 4.23% | 3 |
|
|
2019
Q2 | $36.5M | Sell |
124,132
-1,794
| -1% | -$494K | 4.34% | 3 |
|
|
2019
Q1 | $34.5M | Sell |
125,926
-7,261
| -5% | -$1.81M | 4.36% | 2 |
|
|
2018
Q4 | $29.8M | Buy |
133,187
+306
| +0.2% | +$71.8K | 4.24% | 3 |
|
|
2018
Q3 | $32.4M | Sell |
132,881
-1,920
| -1% | -$442K | 4.25% | 3 |
|
|
2018
Q2 | $27.9M | Sell |
134,801
-4,036
| -3% | -$857K | 4.06% | 8 |
|
|
2018
Q1 | $28.7M | Sell |
138,837
-2,920
| -2% | -$613K | 4.29% | 4 |
|
|
2017
Q4 | $26.9M | Buy |
141,757
+3,264
| +2% | +$625K | 4.07% | 11 |
|
|
2017
Q3 | $26.2M | Sell |
138,493
-5,864
| -4% | -$1.06M | 4.16% | 6 |
|
|
2017
Q2 | $25.2M | Sell |
144,357
-2,315
| -2% | -$389K | 4.1% | 5 |
|
|
2017
Q1 | $22.5M | Buy |
146,672
+3,374
| +2% | +$516K | 3.88% | 16 |
|
|
2016
Q4 | $20.2M | Buy |
143,298
+1,203
| +0.8% | +$177K | 3.77% | 20 |
|
|
2016
Q3 | $22.6M | Sell |
142,095
-2,107
| -1% | -$325K | 4.24% | 4 |
|
|
2016
Q2 | $21.3M | Sell |
144,202
-1,723
| -1% | -$254K | 4.07% | 8 |
|
|
2016
Q1 | $20.7M | Sell |
145,925
-836
| -0.6% | -$112K | 4.11% | 7 |
|
|
2015
Q4 | $20.8M | Sell |
146,761
-2,184
| -1% | -$291K | 4.41% | 1 |
|
|
2015
Q3 | $18.2M | Buy |
148,945
+1,531
| +1% | +$199K | 4.09% | 10 |
|
|
2015
Q2 | $19.1M | Buy |
147,414
+321
| +0.2% | +$41.8K | 4.04% | 8 |
|
|
2015
Q1 | $19.8M | Buy |
147,093
+2,745
| +2% | +$354K | 4.12% | 4 |
|
|
2014
Q4 | $18.1M | Buy |
144,348
+683
| +0.5% | +$83K | 3.86% | 11 |
|
|
2014
Q3 | $17.5M | Sell |
143,665
-42
| -0% | -$5.11K | 3.37% | 9 |
|
|
2014
Q2 | $17M | Sell |
143,707
-3,672
| -2% | -$432K | 3.28% | 14 |
|
|
2014
Q1 | $17.7M | Sell |
147,379
-14,403
| -9% | -$1.71M | 3.54% | 2 |
|
|
2013
Q4 | $18M | Sell |
161,782
-3,410
| -2% | -$339K | 3.63% | 1 |
|
|
2013
Q3 | $15.2M | Sell |
165,192
-67
| -0% | -$6.06K | 3.43% | 3 |
|
|
2013
Q2 | $14M | Buy |
+165,259
| New | +$13.8M | 3.4% | 5 |
|
Other funds holding TMO
VCM
Compass Capital Management's TMO Position: Q1 2026 in Review
Compass Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 7.6% in Q1 2026, selling an estimated $4.69M and leaving 105,632 shares worth $51.9M. The position accounts for 3.14% of the portfolio, ranked #19.
Compass Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $66.2M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Compass Capital Management held 105,632 shares of Thermo Fisher Scientific worth $51.9M as of Q1 2026.
- Compass Capital Management sold 8,651 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.69M.
- Thermo Fisher Scientific made up 3.14% of Compass Capital Management's portfolio in Q1 2026, its #19 holding.
- Compass Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Compass Capital Management's Thermo Fisher Scientific position peaked at $66.2M in Q4 2025.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Compass Capital Management's 13F filing for Q1 2026, filed 21 May 2026.